<DOC>
	<DOCNO>NCT02117206</DOCNO>
	<brief_summary>The symptom severity arterial disease secondary perfusion deficit . The specific alteration mitochondrial function ischemic skeletal muscle play important role , therapeutic enhance mitochondrial function associate clinical improvement increase walk distance patient . In severe ischemia , reperfusion require accompanied deleterious episode worsen endothelial dysfunction ( impaired pathway nitric oxide ( NO ) ) , majorant alteration cellular energy hormonal inflammatory response . This reperfusion syndrome , lead grave consequence . Our goal limit mitochondrial endothelial dysfunction ( increased reperfusion ) stimulate NO pathway situ addition precursor , L-arginine . Our work hypothesis cellular improvement accompany increase systolic pressure index improvement walk distance . Method : This trial direct individual benefit , comparative , randomize , prospective , single-center , double-blind , versus placebo .</brief_summary>
	<brief_title>Protective Effects L-arginine During Reperfusion Femoropopliteal Bypass Lower Limb Ischemic Syndrome Humans</brief_title>
	<detailed_description>2 group 30 patient severe low limb ischemia require femoropopliteal bypass revascularization participate study . The control group ( placebo isoosmotic saline ) compare treat group ( femoral arterial infusion 2 g L-Arginine 30 min ) . Heart rate , blood pressure body temperature monitor continuously . The gastrocnemius muscle biopsied 30 minute revascularization analyze mitochondrial respiration control . Both femoral brachial concomitant venous sample judge importance muscle damage ( lactate , muscle enzyme ) release mediator ( cytokine , NO endothelin ) local general . Main clinical implication : L-arginine supplementation atherosclerotic patient require femoropopliteal bypass limit initial deleterious effect reperfusion improve walk distance therefore quality life . Then extend treatment patient peripheral arterial disease .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<criteria>atherosclerotic patient peripheral arterial disease stage 24 Leriche Fontaine classification require surgical revascularization femoropopliteal bypass 18 year old active infectious disease severe heart disease chronic renal insufficency pregnant woman woman childbearing age effective contraception least three month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>L-arginine</keyword>
</DOC>